SARS-CoV-2 is transmitted via contact and via the air between ferrets.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 07 2020
Historique:
received: 15 04 2020
accepted: 25 06 2020
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 18 7 2020
Statut: epublish

Résumé

SARS-CoV-2, a coronavirus that emerged in late 2019, has spread rapidly worldwide, and information about the modes of transmission of SARS-CoV-2 among humans is critical to apply appropriate infection control measures and to slow its spread. Here we show that SARS-CoV-2 is transmitted efficiently via direct contact and via the air (via respiratory droplets and/or aerosols) between ferrets, 1 to 3 days and 3 to 7 days after exposure respectively. The pattern of virus shedding in the direct contact and indirect recipient ferrets is similar to that of the inoculated ferrets and infectious virus is isolated from all positive animals, showing that ferrets are productively infected via either route. This study provides experimental evidence of robust transmission of SARS-CoV-2 via the air, supporting the implementation of community-level social distancing measures currently applied in many countries in the world and informing decisions on infection control measures in healthcare settings.

Identifiants

pubmed: 32641684
doi: 10.1038/s41467-020-17367-2
pii: 10.1038/s41467-020-17367-2
pmc: PMC7343828
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3496

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 731014
Pays : International

Références

WHO. Pneumonia of unknown cause—China. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/ (2020).
Zhu, N. et al. A Novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
doi: 10.1056/NEJMoa2001017
WHO. Novel Coronavirus—China. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (2020).
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
doi: 10.1038/s41586-020-2012-7
Coronaviridae Study Group of the International Committee on Taxonomy of V. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol 5, 536–544 (2020).
doi: 10.1038/s41564-020-0695-z
WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19–11-march-2020 (2020).
Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020).
doi: 10.1016/S0140-6736(20)30154-9
Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
doi: 10.1016/S0140-6736(20)30183-5
Li, Q. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 382, 1199–1207 (2020).
doi: 10.1056/NEJMoa2001316
Riou, J. & Althaus, C.L. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 25, 2000058 (2020).
Wu, J. T., Leung, K. & Leung, G. M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 395, 689–697 (2020).
doi: 10.1016/S0140-6736(20)30260-9
Kutter, J. S., Spronken, M. I., Fraaij, P. L., Fouchier, R. A. & Herfst, S. Transmission routes of respiratory viruses among humans. Curr. Opin. Virol. 28, 142–151 (2018).
doi: 10.1016/j.coviro.2018.01.001
Liu, J. et al. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg. Infect. Dis. 26, 1320-1323 (2020).
Burke, R. M. et al. Active monitoring of persons exposed to patients with confirmed COVID-19 - United States, January–February 2020. MMWR Morb. Mortal. Wkly Rep. 69, 245–246 (2020).
doi: 10.15585/mmwr.mm6909e1
Martina, B. E. et al. Virology: SARS virus infection of cats and ferrets. Nature 425, 915 (2003).
doi: 10.1038/425915a
ter Meulen, J. et al. Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet 363, 2139–2141 (2004).
doi: 10.1016/S0140-6736(04)16506-9
Weingartl, H. et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J. Virol. 78, 12672–12676 (2004).
doi: 10.1128/JVI.78.22.12672-12676.2004
Chu, Y. K. et al. The SARS-CoV ferret model in an infection-challenge study. Virology 374, 151–163 (2008).
doi: 10.1016/j.virol.2007.12.032
van den Brand, J. M. et al. Pathology of experimental SARS coronavirus infection in cats and ferrets. Vet. Pathol. 45, 551–562 (2008).
doi: 10.1354/vp.45-4-551
Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224 (2020).
doi: 10.1038/s41586-020-2179-y
Kim, Y.I. et al. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe. 27, 704–709.e2 (2020).
Chan, J.F. et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciaa325 (2020).
Shi, J. et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science 368, 1016–1020 (2020).
Munster, V. J. et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325, 481–483 (2009).
doi: 10.1126/science.1177127
Wu, Y. et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet. Gastroenterol. Hepatol. 5, 434–435 (2020).
Ong, S.W.X. et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 323, 1610–1612 (2020).
van Doremalen, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 382, 1564–1567 (2020).
Cheng, V.C.C. et al. Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect. Control Hosp. Epidemiol. 41, 493–498 (2020).
WHO. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations (2020).
van Doornum, G. J., Schutten, M., Voermans, J., Guldemeester, G. J. & Niesters, H. G. Development and implementation of real-time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens. J. Med Virol. 79, 1868–1876 (2007).
doi: 10.1002/jmv.21031
Corman, V.M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, 2000045 (2020).
Okba, N.M.A. et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg. Infect. Dis. 26, 1478–1488 (2020).
Oude Munnink, B.B. et al. Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands. Preprint at https://www.biorxiv.org/content/biorxiv/early/2020/04/25/2020.04.21.050633.full.pdf (2020).

Auteurs

Mathilde Richard (M)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Adinda Kok (A)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Dennis de Meulder (D)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Theo M Bestebroer (TM)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Mart M Lamers (MM)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Nisreen M A Okba (NMA)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Martje Fentener van Vlissingen (M)

Erasmus Laboratory Animal Science Center, Erasmus University Medical Center, Rotterdam, The Netherlands.

Barry Rockx (B)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Bart L Haagmans (BL)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Marion P G Koopmans (MPG)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Ron A M Fouchier (RAM)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands.

Sander Herfst (S)

Department of Viroscience, Erasmus University Medical Center, Rotterdam, The Netherlands. s.herfst@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH